Kirsty Hayes, current British ambassador in Argentina wrote a column, published in Buenos Aires main daily, La Nacion pointing out that April 2nd was the beginning of the saddest page of the wide history of relations between Ar...

Argentina's Economy Minister Martín Guzmán met Friday with US Ambassador Marc Stanley at the Treasury Palace in Buenos Aires to discuss the bilateral agenda regarding cooperation between the two countries.

Bolivia's Yacimientos Petrolíferos Fiscales Bolivianos (YPFB) and Integración Energética Argentina Sociedad Anónima (IEASA) agreed to postpone the decision on a sixth addendum to the contract for the supply of natural gas f...

Next Tuesday a cruise vessel will be calling at Puerto Williams in Chile officially marking the end of the 2021/22 cruise season in that country, which local authorities from Punta Arenas consider very satisfactory, given the a...

The Argentine Government has appointed General Jorge Fabián Berredo to replace General Martín Deimundo Escobal as Operational Commander of the Joint Chiefs of Staff. Escobal is under investigation for alleged mishandling of t...

Argentina's Foreign Minister Santiago Cafiero met Thursday with Chile's new Ambassador to Buenos Aires, ahead of President Gabriel Boric's visit next Sunday in his first trip abroad since taking office.

The Tierra del Fuego provincial Legislative held on Wednesday its first ordinary session of 2022 to approve several decrees and motions referred to the Malvinas Question, and to mark the 40th anniversary of the conflict, trigge...

Argentina's Domestic Trade Secretary Roberto Feletti Thursday admitted that the inflation figures for the month of March "will be bad" following the impact of the war between Russia and Ukraine on the local economy.

The Malvinas Veterans from Ushuaia Center has started April 2nd commemoration activities by inaugurating a Dignity Tent at the Malvinas Heroes Square in the capital of the southernmost Argentine province of Tierra del Fuego, Us...

The first vaccine against COVID-19 developed in Argentina is to be tested on humans during phase 1 trials, it was announced Wednesday in Buenos Aires.